Donor body mass index does not predict graft versus host disease following hematopoietic cell transplantation

Lucie M. Turcotte; Tao Wang; Michael T. Hemmer; Stephen R. Spellman; Mukta Arora; Daniel Couriel; Amin Alousi; Joseph Pidala; Hisham Abdel-Azim; Ibrahim Ahmed; Amer Beitinjaneh; David Buchbinder; Michael Byrne; Natalie Callander; Nelson Chao; Sung Wong Choi; Zachariah Defilipp; Shahinaz M. Gadalla; Robert Peter Gale; Usama Gergis; Shahrukh Hashmi; Peiman Hematti; Leona Holmberg; Yoshihiro Inamoto; Rammurti T. Kamble; Leslie Lehmann; Margaret A. MacMillan; Zachariah McIver; Taiga Nishihori; Maxim Norkin; Tracey O'Brien; Richard F. Olsson; Ran Reshef; Ayman Saad; Bipin N. Savani; Harry C. Schouten; Sachiko Seo; Melhem Solh; Leo Verdonck; Ravi Vij; Baldeep Wirk; Jean Yared; Mary M. Horowitz; Jennifer M. Knight; Michael R. Verneris

doi:10.1038/s41409-018-0100-1

Donor body mass index does not predict graft versus host disease following hematopoietic cell transplantation

Lucie M. Turcotte, Tao Wang, Michael T. Hemmer, Stephen R. Spellman, Mukta Arora, Daniel Couriel, Amin Alousi, Joseph Pidala, Hisham Abdel-Azim, Ibrahim Ahmed, Amer Beitinjaneh, David Buchbinder, Michael Byrne, Natalie Callander, Nelson Chao, Sung Wong Choi, Zachariah Defilipp, Shahinaz M. Gadalla, Robert Peter Gale, Usama GergisShahrukh Hashmi, Peiman Hematti, Leona Holmberg, Yoshihiro Inamoto, Rammurti T. Kamble, Leslie Lehmann, Margaret A. MacMillan, Zachariah McIver, Taiga Nishihori, Maxim Norkin, Tracey O'Brien, Richard F. Olsson, Ran Reshef, Ayman Saad, Bipin N. Savani, Harry C. Schouten, Sachiko Seo, Melhem Solh, Leo Verdonck, Ravi Vij, Baldeep Wirk, Jean Yared, Mary M. Horowitz, Jennifer M. Knight, Michael R. Verneris

Stem Cell Transplantation

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Original language	English (US)
Pages (from-to)	932-937
Number of pages	6
Journal	Bone marrow transplantation
Volume	53
Issue number	7
DOIs	https://doi.org/10.1038/s41409-018-0100-1
State	Published - Jul 1 2018

ASJC Scopus subject areas

Hematology
Transplantation

Access to Document

10.1038/s41409-018-0100-1

Cite this

Turcotte, L. M., Wang, T., Hemmer, M. T., Spellman, S. R., Arora, M., Couriel, D., Alousi, A., Pidala, J., Abdel-Azim, H., Ahmed, I., Beitinjaneh, A., Buchbinder, D., Byrne, M., Callander, N., Chao, N., Choi, S. W., Defilipp, Z., Gadalla, S. M., Gale, R. P., ... Verneris, M. R. (2018). Donor body mass index does not predict graft versus host disease following hematopoietic cell transplantation. Bone marrow transplantation, 53(7), 932-937. https://doi.org/10.1038/s41409-018-0100-1

Turcotte, LM, Wang, T, Hemmer, MT, Spellman, SR, Arora, M, Couriel, D, Alousi, A, Pidala, J, Abdel-Azim, H, Ahmed, I, Beitinjaneh, A, Buchbinder, D, Byrne, M, Callander, N, Chao, N, Choi, SW, Defilipp, Z, Gadalla, SM, Gale, RP, Gergis, U, Hashmi, S, Hematti, P, Holmberg, L, Inamoto, Y, Kamble, RT, Lehmann, L, MacMillan, MA, McIver, Z, Nishihori, T, Norkin, M, O'Brien, T, Olsson, RF, Reshef, R, Saad, A, Savani, BN, Schouten, HC, Seo, S, Solh, M, Verdonck, L, Vij, R, Wirk, B, Yared, J, Horowitz, MM, Knight, JM & Verneris, MR 2018, 'Donor body mass index does not predict graft versus host disease following hematopoietic cell transplantation', Bone marrow transplantation, vol. 53, no. 7, pp. 932-937. https://doi.org/10.1038/s41409-018-0100-1

@article{c4739920aad542e29ecfa9112487c5b7,

title = "Donor body mass index does not predict graft versus host disease following hematopoietic cell transplantation",

author = "Turcotte, {Lucie M.} and Tao Wang and Hemmer, {Michael T.} and Spellman, {Stephen R.} and Mukta Arora and Daniel Couriel and Amin Alousi and Joseph Pidala and Hisham Abdel-Azim and Ibrahim Ahmed and Amer Beitinjaneh and David Buchbinder and Michael Byrne and Natalie Callander and Nelson Chao and Choi, {Sung Wong} and Zachariah Defilipp and Gadalla, {Shahinaz M.} and Gale, {Robert Peter} and Usama Gergis and Shahrukh Hashmi and Peiman Hematti and Leona Holmberg and Yoshihiro Inamoto and Kamble, {Rammurti T.} and Leslie Lehmann and MacMillan, {Margaret A.} and Zachariah McIver and Taiga Nishihori and Maxim Norkin and Tracey O'Brien and Olsson, {Richard F.} and Ran Reshef and Ayman Saad and Savani, {Bipin N.} and Schouten, {Harry C.} and Sachiko Seo and Melhem Solh and Leo Verdonck and Ravi Vij and Baldeep Wirk and Jean Yared and Horowitz, {Mary M.} and Knight, {Jennifer M.} and Verneris, {Michael R.}",

note = "Funding Information: Acknowledgements This work was funded in part by the Children{\textquoteright}s Cancer Research Fund, Minneapolis, MN (LMT) and the National Center for Advancing Translational Sciences (National Institutes of Health (NIH)) through Grant Numbers UL1TR001436 and KL2TR001438 (JMK). The CIBMTR is supported primarily by Public Health Service Grant/Cooperative Agreement 5U24CA076518 from the National Cancer Institute (NCI), the National Heart, Lung and Blood Institute (NHLBI) and the National Institute of Allergy and Infectious Diseases (NIAID); a Grant/Cooperative Agreement 4U10HL069294 from NHLBI and NCI; a contract HHSH250201200016C with Health Resources and Services Administration (HRSA/DHHS); two Grants N00014-17-1-2388 and N0014-17-1-2850 from the Office of Naval Research; and grants from *Actinium Pharmaceuticals, Inc.; *Amgen, Inc.; *Amneal Biosciences; *Angiocrine Bioscience, Inc.; Anonymous donation to the Medical College of Wisconsin; Astellas Pharma US; Atara Biother-apeutics, Inc.; Be the Match Foundation; *bluebird bio, Inc.; *Bristol Myers Squibb Oncology; *Celgene Corporation; Cerus Corporation; *Chimerix, Inc.; Fred Hutchinson Cancer Research Center; Gamida Cell Ltd.; Gilead Sciences, Inc.; HistoGenetics, Inc.; Immucor; *Incyte Corporation; Janssen Scientific Affairs, LLC; *Jazz Pharmaceuticals, Inc.; Juno Therapeutics; Karyopharm Therapeutics, Inc.; Kite Pharma, Inc.; Medac, GmbH; MedImmune; The Medical College of Wisconsin; *Mediware; *Merck & Co, Inc.; *Mesoblast; MesoScale Diagnostics, Inc.; Millennium, the Takeda Oncology Co.; *Miltenyi Biotec, Inc.; National Marrow Donor Program; *Neovii Biotech NA, Inc.; Novartis Pharmaceuticals Corporation; Otsuka Pharmaceutical Co, Ltd.—Japan; PCORI; *Pfizer, Inc; *Pharmacyclics, LLC; PIRCHE AG; *Sanofi Genzyme; *Seattle Genetics; Shire; Spectrum Pharmaceuticals, Inc.; St. Baldrick{\textquoteright}s Foundation; *Sunesis Pharmaceuticals, Inc.; Swedish Orphan Biovitrum, Inc.; Takeda Oncology; Telomere Diagnostics, Inc.; and University of Minnesota. The views expressed in this article do not reflect the official policy or position of the National Institute of Health, the Department of the Navy, the Department of Defense, Health Resources and Services Administration (HRSA) or any other agency of the U.S. Government. *Corporate Members Author contributions All listed authors participated in: (1) the conception and/or design of this study, data acquisition, and/or result interpretation; (2) drafting or revising the manuscript; and (3) approval of the final submitted manuscript. Dr. Turcotte has had full access to the data in the study and takes responsibility for the decision to submit for publication.",

year = "2018",

month = jul,

day = "1",

doi = "10.1038/s41409-018-0100-1",

language = "English (US)",

volume = "53",

pages = "932--937",

journal = "Bone marrow transplantation",

issn = "0268-3369",

publisher = "Nature Publishing Group",

number = "7",

}

TY - JOUR

T1 - Donor body mass index does not predict graft versus host disease following hematopoietic cell transplantation

AU - Turcotte, Lucie M.

AU - Wang, Tao

AU - Hemmer, Michael T.

AU - Spellman, Stephen R.

AU - Arora, Mukta

AU - Couriel, Daniel

AU - Alousi, Amin

AU - Pidala, Joseph

AU - Abdel-Azim, Hisham

AU - Ahmed, Ibrahim

AU - Beitinjaneh, Amer

AU - Buchbinder, David

AU - Byrne, Michael

AU - Callander, Natalie

AU - Chao, Nelson

AU - Choi, Sung Wong

AU - Defilipp, Zachariah

AU - Gadalla, Shahinaz M.

AU - Gale, Robert Peter

AU - Gergis, Usama

AU - Hashmi, Shahrukh

AU - Hematti, Peiman

AU - Holmberg, Leona

AU - Inamoto, Yoshihiro

AU - Kamble, Rammurti T.

AU - Lehmann, Leslie

AU - MacMillan, Margaret A.

AU - McIver, Zachariah

AU - Nishihori, Taiga

AU - Norkin, Maxim

AU - O'Brien, Tracey

AU - Olsson, Richard F.

AU - Reshef, Ran

AU - Saad, Ayman

AU - Savani, Bipin N.

AU - Schouten, Harry C.

AU - Seo, Sachiko

AU - Solh, Melhem

AU - Verdonck, Leo

AU - Vij, Ravi

AU - Wirk, Baldeep

AU - Yared, Jean

AU - Horowitz, Mary M.

AU - Knight, Jennifer M.

AU - Verneris, Michael R.

N1 - Funding Information: Acknowledgements This work was funded in part by the Children’s Cancer Research Fund, Minneapolis, MN (LMT) and the National Center for Advancing Translational Sciences (National Institutes of Health (NIH)) through Grant Numbers UL1TR001436 and KL2TR001438 (JMK). The CIBMTR is supported primarily by Public Health Service Grant/Cooperative Agreement 5U24CA076518 from the National Cancer Institute (NCI), the National Heart, Lung and Blood Institute (NHLBI) and the National Institute of Allergy and Infectious Diseases (NIAID); a Grant/Cooperative Agreement 4U10HL069294 from NHLBI and NCI; a contract HHSH250201200016C with Health Resources and Services Administration (HRSA/DHHS); two Grants N00014-17-1-2388 and N0014-17-1-2850 from the Office of Naval Research; and grants from *Actinium Pharmaceuticals, Inc.; *Amgen, Inc.; *Amneal Biosciences; *Angiocrine Bioscience, Inc.; Anonymous donation to the Medical College of Wisconsin; Astellas Pharma US; Atara Biother-apeutics, Inc.; Be the Match Foundation; *bluebird bio, Inc.; *Bristol Myers Squibb Oncology; *Celgene Corporation; Cerus Corporation; *Chimerix, Inc.; Fred Hutchinson Cancer Research Center; Gamida Cell Ltd.; Gilead Sciences, Inc.; HistoGenetics, Inc.; Immucor; *Incyte Corporation; Janssen Scientific Affairs, LLC; *Jazz Pharmaceuticals, Inc.; Juno Therapeutics; Karyopharm Therapeutics, Inc.; Kite Pharma, Inc.; Medac, GmbH; MedImmune; The Medical College of Wisconsin; *Mediware; *Merck & Co, Inc.; *Mesoblast; MesoScale Diagnostics, Inc.; Millennium, the Takeda Oncology Co.; *Miltenyi Biotec, Inc.; National Marrow Donor Program; *Neovii Biotech NA, Inc.; Novartis Pharmaceuticals Corporation; Otsuka Pharmaceutical Co, Ltd.—Japan; PCORI; *Pfizer, Inc; *Pharmacyclics, LLC; PIRCHE AG; *Sanofi Genzyme; *Seattle Genetics; Shire; Spectrum Pharmaceuticals, Inc.; St. Baldrick’s Foundation; *Sunesis Pharmaceuticals, Inc.; Swedish Orphan Biovitrum, Inc.; Takeda Oncology; Telomere Diagnostics, Inc.; and University of Minnesota. The views expressed in this article do not reflect the official policy or position of the National Institute of Health, the Department of the Navy, the Department of Defense, Health Resources and Services Administration (HRSA) or any other agency of the U.S. Government. *Corporate Members Author contributions All listed authors participated in: (1) the conception and/or design of this study, data acquisition, and/or result interpretation; (2) drafting or revising the manuscript; and (3) approval of the final submitted manuscript. Dr. Turcotte has had full access to the data in the study and takes responsibility for the decision to submit for publication.

PY - 2018/7/1

Y1 - 2018/7/1

UR - http://www.scopus.com/inward/record.url?scp=85041181961&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85041181961&partnerID=8YFLogxK

U2 - 10.1038/s41409-018-0100-1

DO - 10.1038/s41409-018-0100-1

M3 - Letter

C2 - 29382954

AN - SCOPUS:85041181961

SN - 0268-3369

VL - 53

SP - 932

EP - 937

JO - Bone marrow transplantation

JF - Bone marrow transplantation

IS - 7

ER -

Donor body mass index does not predict graft versus host disease following hematopoietic cell transplantation

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this